BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19634715)

  • 21. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
    Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
    J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
    Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice.
    Mazumder S; Ravindran R; Banerjee A; Ali N
    Vaccine; 2007 Dec; 25(52):8771-81. PubMed ID: 18031874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
    J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
    Bhattacharjee S; Gupta G; Bhattacharya P; Mukherjee A; Mujumdar SB; Pal A; Majumdar S
    J Antimicrob Chemother; 2009 Feb; 63(2):317-24. PubMed ID: 19036753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
    Sane SA; Shakya N; Haq W; Gupta S
    J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis.
    Guha R; Gupta D; Rastogi R; Vikram R; Krishnamurthy G; Bimal S; Roy S; Mukhopadhyay A
    Sci Transl Med; 2013 Sep; 5(202):202ra121. PubMed ID: 24027025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with Leishmania donovani.
    Bimal S; Bagchi AK; Das V; Sinha PK; Lal CS; Ranjan A; Gupta AK; Kar SK
    Indian J Exp Biol; 2001 Sep; 39(9):878-82. PubMed ID: 11831368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms.
    Kar S; Ukil A; Sharma G; Das PK
    J Leukoc Biol; 2010 Jul; 88(1):9-20. PubMed ID: 20200403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radio-attenuated leishmanial parasites as immunoprophylactic agent against experimental murine visceral leishmaniasis.
    Datta S; Adak R; Chakraborty P; Haldar AK; Bhattacharjee S; Chakraborty A; Roy S; Manna M
    Exp Parasitol; 2012 Jan; 130(1):39-47. PubMed ID: 22019416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of Croton caudatus Geisel leaf extract against experimental visceral leishmaniasis induces proinflammatory cytokines in vitro and in vivo.
    Dey S; Mukherjee D; Chakraborty S; Mallick S; Dutta A; Ghosh J; Swapana N; Maiti S; Ghorai N; Singh CB; Pal C
    Exp Parasitol; 2015; 151-152():84-95. PubMed ID: 25655407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
    Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
    Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.
    Murray HW; Montelibano C; Peterson R; Sypek JP
    J Infect Dis; 2000 Nov; 182(5):1497-502. PubMed ID: 11023473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
    Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
    Khoshgoo N; Zahedifard F; Azizi H; Taslimi Y; Alonso MJ; Rafati S
    Vaccine; 2008 Oct; 26(46):5822-9. PubMed ID: 18804512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
    Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
    Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12.
    Adhikari A; Gupta G; Majumder S; Banerjee S; Bhattacharjee S; Bhattacharya P; Kumari S; Haldar S; Majumdar SB; Saha B; Majumdar S
    PLoS One; 2012; 7(7):e40265. PubMed ID: 22792256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.